This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
Reference is made to the report by Dr Berchou (Archives 36:522-523, 1979) concerning a case of oculogyric crisis occurring in association with carbamazepine (Tegretol) therapy. In our discussion with Dr Berchou prior to his published report, we noted that oculomotor disturbances are listed in our package insert for carbamazepine as possible adverse reactions. The clinical findings described by Dr Berchou would be included under that classification. Those oculomotor disturbances that have been reported seem to be related to dosage, and usually are controlled by titration of carbamazepine to the minimum effective dose level.
Henry EV. Oculogyric Crisis and Carbamazepine. Arch Neurol. 1980;37(5):326. doi:10.1001/archneur.1980.00500540104030
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: